Sellas Life Sciences Group Inc (SLS) Stock Forecast & Price Target
Sellas Life Sciences Group Inc · NASDAQ
$10.84-0.48 (-4.28%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 1 firms covering Sellas Life Sciences Group Inc, 1 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $10.00 to $10.00, so the covering firms are broadly aligned. The average target of $10.00 sits 8% below the current $10.84. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.06 next quarter toward $-0.13 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS1 ratings
Moderate Buy
Strong Buy00%
Buy1100%
Hold00%
Sell00%
Strong Sell00%
Based on 1 analysts giving stock ratings to Sellas Life Sciences Group Inc.
As of Jul, 1 of 1 firms rate SLS a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
SLS EPS & revenue forecast
EPS · NEXT QUARTER
$-0.06
Range $-0.06 – $-0.05 · 2 analysts · -8% YoY
Next period, 2 analysts expect Sellas Life Sciences Group Inc to earn $-0.06 a share (range $-0.06 – $-0.05), versus $-0.06 a year earlier. Full-year consensus is $-0.21, growing to $-0.13 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 2 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $53.1M next year.
Top analysts covering Sellas Life Sciences Group Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on SLS.
#1
Jason McCarthy
Maxim Group · Rank #360
Buy
$10.00-7.7% to target
Overall win rate
30%
+ Follow
SLS stock forecast FAQ
What is SLS's average 12-month price target?+
The 1 analysts with a live target average $10.00 for Sellas Life Sciences Group Inc over the next 12 months, ranging from a $10.00 high to a $10.00 low.
Is SLS stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 1 analyst ratings, 1 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover SLS?+
1 analysts have an active rating on Sellas Life Sciences Group Inc, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering SLS?+
Among analysts who currently cover SLS, Jason McCarthy of Maxim Group has the strongest overall Quantellect track record (Rank #360). Their current call is Buy with a $10.00 target.
What is Sellas Life Sciences Group Inc's projected EPS for next quarter?+
The consensus estimate is $-0.06 per share (range $-0.06 – $-0.05) across 2 analysts. Full-year EPS is projected at $-0.21, rising to $-0.13 the following year.
How much revenue is Sellas Life Sciences Group Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $53.1M next year.
Have analysts been upgrading or downgrading SLS lately?+
As of Jul, 1 of 1 firms rate SLS a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their SLS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
